Literature DB >> 9891702

Wilson's disease. Update of a systemic disorder with protean manifestations.

J A Cuthbert1.   

Abstract

In Wilson's disease, a genetic defect in a copper transporter causes defective incorporation of copper into apo-ceruloplasmin and the failure to excrete copper into bile. Copper accumulated in hepatocytes generates damage via reactive oxygen species. Release of copper from necrotic hepatocytes leads to damage of other tissues, including the brain, urinary tract, red blood cells, heart, endocrine glands, skin, pancreas, bones, and joints. Treatment is designed to chelate the excess copper for urinary excretion, prevent copper absorption, and render tissue copper nontoxic. Liver transplantation, with replacement of the defective hepatic gene, may be necessary in some cases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9891702     DOI: 10.1016/s0889-8553(05)70025-x

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  9 in total

Review 1.  Classification and differential diagnosis of Wilson's disease.

Authors:  Wieland Hermann
Journal:  Ann Transl Med       Date:  2019-04

2.  [Classification of Wilson's disease based on neurophysiological parameters].

Authors:  W Hermann; P Günther; A Wagner; T Villmann
Journal:  Nervenarzt       Date:  2005-06       Impact factor: 1.214

3.  Evidence that translation reinitiation leads to a partially functional Menkes protein containing two copper-binding sites.

Authors:  Marianne Paulsen; Connie Lund; Zarqa Akram; Jakob R Winther; Nina Horn; Lisbeth Birk Møller
Journal:  Am J Hum Genet       Date:  2006-06-05       Impact factor: 11.025

Review 4.  Diagnosis and treatment of Wilson's disease.

Authors:  Indu Subramanian; Zeba F Vanek; Jeff M Bronstein
Journal:  Curr Neurol Neurosci Rep       Date:  2002-07       Impact factor: 5.081

5.  Pyridoxal isonicotinoyl hydrazone (PIH) prevents copper-mediated in vitro free radical formation.

Authors:  M Hermes-Lima; M S Gonçalves; R G Andrade
Journal:  Mol Cell Biochem       Date:  2001-12       Impact factor: 3.396

6.  Copper transportion of WD protein in hepatocytes from Wilson disease patients in vitro.

Authors:  G Q Hou; X L Liang; R Chen; L W Tang; Y Wang; P Y Xu; Y R Zhang; C H Ou
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

7.  [44-year-old patient with fulminant liver failure].

Authors:  A Kerber; C Sarrazin; C Allers; B Markus; K Engels; W Caspary; S Zeuzem
Journal:  Internist (Berl)       Date:  2003-10       Impact factor: 0.743

8.  Activation of metallothioneins and alpha-crystallin/sHSPs in human lens epithelial cells by specific metals and the metal content of aging clear human lenses.

Authors:  John R Hawse; Jonathan R Cumming; Brian Oppermann; Nancy L Sheets; Venkat N Reddy; Marc Kantorow
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-02       Impact factor: 4.799

Review 9.  [Diagnostics of Wilson's disease].

Authors:  W Hermann; D Huster
Journal:  Nervenarzt       Date:  2018-02       Impact factor: 1.214

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.